Zevra Therapeutics Inc (ZVRA)

Dec 20, 2024

(ZVRA) Investment Analysis and Advice - Stock Traders Daily

Dec 20, 2024

Dec 19, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Position Increased by Charles Schwab Investment Management Inc. - Defense World

Dec 19, 2024

Dec 17, 2024

Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024 - The Manila Times

Dec 17, 2024

Dec 17, 2024

Zevra Therapeutics Secures Coveted Spot in Nasdaq Biotechnology Index Following Transformative Year - StockTitan

Dec 17, 2024

Dec 15, 2024

Zevra Therapeutics' SWOT analysis: rare disease drug maker's stock poised for growth - Investing.com

Dec 15, 2024

Dec 11, 2024

Fmr LLC Acquires 2,312,384 Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Dec 11, 2024

Dec 09, 2024

Zevra Therapeutics Restructures to Focus on Rare Diseases - MSN

Dec 09, 2024

Dec 09, 2024

A drug for fewer than 1,000 patients? Awareness and diagnosis are key. - PharmaVoice

Dec 09, 2024

Dec 06, 2024

Zevra Therapeutics, Inc. Announces Departure of Executives - Marketscreener.com

Dec 06, 2024

Dec 06, 2024

Zevra Therapeutics Announces Organizational Changes - The Manila Times

Dec 06, 2024

Dec 06, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) has caught the attention of institutional investors who hold a sizeable 42% stake - Yahoo Finance

Dec 06, 2024

Dec 02, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives $21.00 Consensus Price Target from Brokerages - MarketBeat

Dec 02, 2024

Nov 29, 2024

Vestal Point Capital LP Purchases Shares of 525,000 Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Nov 29, 2024

Nov 26, 2024

179,874 Shares in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Purchased by Propel Bio Management LLC - MarketBeat

Nov 26, 2024

Nov 26, 2024

Zevra Therapeutics to Participate at Upcoming Investor Conferences - The Manila Times

Nov 26, 2024

Nov 26, 2024

Zevra Therapeutics CEO to Present at Major Healthcare Investment Conferences | ZVRA Stock News - StockTitan

Nov 26, 2024

Nov 23, 2024

Zevra Therapeutics (NASDAQ:ZVRA) Reaches New 52-Week HighShould You Buy? - MarketBeat

Nov 23, 2024

Nov 23, 2024

Zevra Therapeutics Launches MIPLYFFA for Niemann-Pick Disease - Yahoo Finance

Nov 23, 2024

Nov 23, 2024

What is HC Wainwright’s Forecast for ZVRA FY2024 Earnings? - Defense World

Nov 23, 2024

Nov 22, 2024

ZVRA stock touches 52-week high at $9.6 amid robust growth - Investing.com UK

Nov 22, 2024

Nov 22, 2024

Equities Analysts Set Expectations for ZVRA FY2024 Earnings - MarketBeat

Nov 22, 2024

Nov 22, 2024

Zevra launches first FDA-approved NPC treatment By Investing.com - Investing.com Australia

Nov 22, 2024

Nov 22, 2024

Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C - The Manila Times

Nov 22, 2024

Nov 21, 2024

Zevra launches first FDA-approved NPC treatment - Investing.com India

Nov 21, 2024

Nov 21, 2024

HC Wainwright Has Negative Forecast for ZVRA FY2028 Earnings - MarketBeat

Nov 21, 2024

Nov 20, 2024

Zevra Therapeutics (NASDAQ:ZVRA) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 20, 2024

Nov 20, 2024

Guggenheim Initiates Coverage of Zevra Therapeutics (ZVRA) with Buy Recommendation - MSN

Nov 20, 2024

Nov 20, 2024

Zevra Therapeutics (STU:1GDA) Enterprise Value : €424.12 Mil (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024

Nov 20, 2024

Zevra Therapeutics Q3 2024 Earnings Preview - MSN

Nov 20, 2024

Nov 20, 2024

Zevra Therapeutics (ZVRA) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 20, 2024

Nov 18, 2024

(ZVRA) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 18, 2024

Nov 18, 2024

Cantor Fitzgerald Issues Negative Estimate for ZVRA Earnings - MarketBeat

Nov 18, 2024

Nov 18, 2024

What is William Blair's Forecast for ZVRA FY2024 Earnings? - MarketBeat

Nov 18, 2024

Nov 16, 2024

Analysts Have Made A Financial Statement On Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Third-Quarter Report - Yahoo Finance

Nov 16, 2024

Nov 15, 2024

Zevra testing beta blocker celiprolol for vEDS in Phase 3 US study - Ehlers-Danlos News

Nov 15, 2024

Nov 15, 2024

Simplify Asset Management Inc. Invests $833,000 in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Nov 15, 2024

Nov 15, 2024

What is William Blair's Estimate for ZVRA FY2026 Earnings? - MarketBeat

Nov 15, 2024

Nov 15, 2024

Here's What Analysts Are Forecasting For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) After Its Third-Quarter Results - Simply Wall St

Nov 15, 2024

Nov 15, 2024

Roth Capital Forecasts Lower Earnings for Zevra Therapeutics - MarketBeat

Nov 15, 2024

Nov 15, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Sees Large Decline in Short Interest - MarketBeat

Nov 15, 2024

Nov 14, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 14, 2024

Nov 14, 2024

Earnings call: Zevra Therapeutics reports Q3 financial results - Investing.com

Nov 14, 2024

Nov 14, 2024

Canaccord Genuity Group Issues Pessimistic Forecast for Zevra Therapeutics (NASDAQ:ZVRA) Stock Price - MarketBeat

Nov 14, 2024

Nov 14, 2024

Q4 Earnings Forecast for ZVRA Issued By Roth Capital - MarketBeat

Nov 14, 2024

Nov 14, 2024

Zevra Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 14, 2024

Nov 14, 2024

Woodline Partners LP's Strategic Acquisition of Zevra Therapeuti - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

Janney Montgomery Scott LLC Sells 127,755 Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Nov 13, 2024

Nov 13, 2024

Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates - The Manila Times

Nov 13, 2024

Nov 13, 2024

Zevra Therapeutics Inc (ZVRA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Financial Challenges - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Zevra Therapeutics Inc (ZVRA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ... - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

Zevra Therapeutics’ Transformative Third Quarter 2024 - TipRanks

Nov 12, 2024

Nov 12, 2024

Zevra Therapeutics: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 12, 2024